TLX News: Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab - 11th Apr 2022, 8:51am

[annb0t]

MELBOURNE, Australia and INDIANAPOLIS, April 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Company ("Lilly") under which Telix is granted exclusive worldwide rights to develop and commercialise radiolabelled forms of Lilly's olaratumab antibody for the diagnosis and treatment of human cancers. Telix's initial development focus will be on a rare type of cancer known as soft ...

>>> Read more: Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab